𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha-dihydroergocryptine in Parkinson's disease: a multiceuntre randomized double blind parallel group study

✍ Scribed by L. Battistin; P. G. Bardin; F. Ferro-Milone; C. Ravenna; V. Toso; G. Reboldi

Book ID
109336914
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
661 KB
Volume
99
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind trial of tran
A randomized, double-blind trial of transcranial electrostimulation in early Parkinson's disease
✍ Holly A. Shill; Sanja Obradov; Yakov Katsnelson; Ray Pizinger πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract We studied the effects of noninvasive transcranial electrical stimulation on the motor and psychological symptoms of early Parkinson's disease. Twenty‐three subjects were treated with 10 days of placebo versus active treatment and then followed for 14 weeks. Baseline off medication Unif

Botulinum toxin type A for drooling in P
Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study
✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla